Understanding the biophysical basis of FLASH radiotherapy
School of Medicine, Dentistry and Biomedical Sciences
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
Dr McMahon’s research focuses on applying mathematical and computational techniques to better understand and optimise responses to radiation therapy for cancer. These techniques are applied in a range of areas including predicting variations in individual radiation sensitivity based on underlying genetic features, and better understanding the effects of different types of radiation such as X-rays, protons, and carbon ions. By linking these models with the clinic, they can bridge the gap between lab and clinic and inform future radiotherapy treatments.
- Dr Stephen McMahon: School of Medicine, Dentistry and Biomedical Sciences
Contact info
- View Academic Profile
- askmhls@qub.ac.uk
- +44 (0)28 9097 2620
Research Interests
Open to PhD applications in the field of
Make a PhD enquiry
- Proton and ion relative biological effectiveness
- Genetic determinants of intrinsic radiosensitivity
- The impacts of intercellular communication on radiation responses
- Computational modelling of cancer responses
Current Research Opportunities
- Understanding the biophysical basis of FLASH radiotherapy
Public outreach & key achievements
- UKRI Future Leaders Fellowship (2020- )
- Queen’s University Research Fellowship (2017-2020)
- Marie Curie International Fellowship (2014-2017)
Research students
PhD Title | Understanding the role of intercellular signalling and immnune modulation in radiotherapy
Country | Northern Ireland
PhD Title | Applications of laser driven particle accelerators for ultra high dose rate radiotherapy
Country | Northern Ireland
PhD Title | Modelling DNA damage and repair in radiation therapy
Country | Northern Ireland
Discover More
- Faculty of Medicine, Health and Life Sciences
- School of Medicine, Dentistry and Biomedical Sciences
- The Patrick G Johnston Centre for Cancer Research
- Advanced Radiotherapy Group